Yissum
Highly Engaged Employees
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box, Jerusalem, Jerusalem, 39135, Isr...Phone Number
+972 26586693Website
www.yissum.co.ilRevenue
$7.7 MillionIndustry
About Yissum
Yissum Org Chart
Is Yissum your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Yissum, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Yissum has new funding data
Check out if Yissum is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Yissum had a recent Job posting/layoffs
Product Launch: Get notified when Yissum launches new products
Check if Yissum has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Yissum recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Yissum
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Yissum is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Yissum is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Yissum.
Yissum financials insights
Gather financial insights about Yissum, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$5M
Yissum Tech Stack
A closer look at the technologies used by Yissum
Yissum News & Media
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
First-in-human studies anticipated to begin in 2026Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
Innovative compounds designed to address critical unmet needs in PTSD treatmentClearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
Vancouver, Canada, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the submission of a patent application under the international Patent Cooperation Treaty (“PCT”) as part of the company’s ongoing collaboration with the with Yissum Research Development Company of the HebSciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced that an additional patent application with the United States Patent and Trademark Office (“USPTO”) was submitted as part of its ongoing collaboration with Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind"), a
Top Business Services Companies
Frequently Asked Questions Regarding Yissum
Yissum is the technology transfer company of the Hebrew University of Jerusalem, acting as a bridge between innovative research and global markets. The company collaborates with researchers, industry partners, and entrepreneurs to transform groundbreaking technologies into impactful ventures. Yissum focuses on various sectors including AgTech, phar... Read More